Anthony Rodriguez
Associate Director Pyxis Oncology
Anthony Rodriguez is a Senior Scientist at Pyxis Oncology, focused on advancing next-generation immuno-oncology therapies. An experienced immunologist with over a decade in research, he earned his doctorate from the University of Virginia and has held roles at institutions including The Rockefeller University. At Pyxis, his work includes the development ADCs, including contributions to the company’s MICVO program, aimed at improving targeted delivery and efficacy of cancer therapeutics for difficult-to-treat tumors.
Seminars
Tuesday 13th October 2026
Characterizing MICVO’s Anti-Tumor, Immunostimulatory & Synergistic Activity in Immunotherapy-Sensitive & Refractory Tumor Models
3:00 pm
- Exploring MICVO targeting EDB+FN, a non-cellular tumor ECM structural component
- Evaluating maMICVO to inhibit tumor growth and modulate the tumor-immune microenvironment in syngeneic tumor models
- Combining maMICVO and anti-PD-1 treatments to demonstrate synergistic anti-tumor activity across syngeneic tumor models, including HNSCC
- Preclinical findings support the ongoing clinical development of MICVO as a monotherapy and in combination with pembrolizumab for R/M HNSCC
